It has long been known that Type I (insulin-dependent) diabetes mellitus considerably increases the risk of pre-eclampsia and maternal and fetal co-morbidity [1±3]. The most important risk factor of pre-eclampsia in women with diabetes is nephropathy (White's class F) [1] . Even incipient nephropathy substantially increases the risk [4] . In addition, retinopathy and long duration of diabetes also increase the risk of pre-eclampsia [5±8].
caemic control differs from that in the general obstetric population. Furthermore, improvement of glucose control during pregnancy might reduce the risk of pre-eclampsia [9] but the magnitude of this reduction is not known. The results of previous studies have often been inconclusive due to small size, retrospective nature, lack of non-diabetic control subjects, or lack of multivariate analysis to control for confounding factors. Some of the studies are old and do not necessarily reflect the clinical setting of the last decade.
We carried out a 10-year population-based followup study of women with Type I diabetes to examine the effect of glucose control and several other factors on the occurrence of hypertensive-pregnancy complications.
Subjects and methods
Women with Type I diabetes. From 1988 to 1997, we followed up 683 pregnancies that lasted at least 20 weeks in 480 women diagnosed with Type I diabetes before pregnancy. As outpatients the women attended the Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, at 2±6 week intervals and more frequently during the third trimester. This is the only centre responsible for the obstetric care of insulin-dependent women in the greater Helsinki area with a population of 1.5 million. The local ethics committee accepted the study protocol and subjects gave their informed consent.
Follow-up. The patients were advised to measure their blood glucose concentration at home five times a day, 2±3 days a week. Insulin was given using a long-acting preparation one to two times daily and a short-acting one at meals, mostly three to four times a day. An appointment with an ophthalmologist was arranged for the period of early pregnancy if the last evaluation of retinopathy had preceded the pregnancy by more than 6 months. Meticulous adherence to diet was promoted, and consultation with a dietitian arranged when needed.
Ultrasonography was carried out every 4±8 weeks and monitoring by cardiotocography at each visit after 28 weeks and twice weekly after 34 weeks of gestation. The patients routinely underwent amniocentesis at 37 weeks (or earlier if needed) and delivery electively when the fetal lungs were mature. Caesarean delivery was preferred in patients of White's class D or higher and in others who developed additional risk factors such as fetal macrosomia or signs of fetal distress.
Control subjects. The control subjects comprised 854 non-selected pregnancies consecutively in 827 women residing in Kerava (a town in the middle of the hospital's catchment area) who participated in routine 18-week ultrasonography screening during 1993 and 1994. Women whose pregnancies ended before 20 weeks and those with gestational diabetes requiring insulin treatment, were excluded. The control subjects were seen by a doctor three to four times and by a midwife every 4 weeks until 28 weeks, every 2 weeks until 36 weeks and weekly thereafter.
Measurement of blood pressure and proteinuria. Blood pressure was measured after rest with the subject in a sitting or semi-recumbent position. The measurements were carried out as part of the routine clinical follow-up by midwives and nurses with long clinical experience.
Blood pressure during pregnancy was considered increased when the following two criteria were met at two measuring sessions of at least 24 h apart: First, diastolic pressure increased 15 mmHg or more from the first measurement during pregnancy until the end of pregnancy, and second, the final level reached 90 mmHg or more. Of the measurements, the second highest was used for analysis.
Urine was checked for protein by a dipstick method at each clinical visit. Results of ª + + º or repeated ª + º were confirmed by quantitative analysis. A diagnosis of proteinuria was made if the amount of protein was 0.3 g or more/24 h.
Definitions of hypertensive pregnancy complications. Pre-eclampsia was defined as high blood pressure and proteinuria at the end of pregnancy, as described above. Pregnancy-induced hypertension (PIH) was defined as high blood pressure without proteinuria. These two conditions were thus mutually exclusive. A third category comprised subjects with neither of these conditions.
A different definition of pre-eclampsia and PIH had to be used for subjects with nephropathy before pregnancy (White's class F) who, by definition, already have constant proteinuria. They were considered to have pre-eclampsia or PIH if the above-mentioned blood pressure criteria alone were met.
Assessment of glycaemic control. Haemoglobin A 1 c was assessed every 4 to 6 weeks by HPLC (Diamat, Bio-Rad Laboratories, Hercules, Calif., USA). The mean HbA 1 c value as assessed by this method is 4.93 % (SD 0.32) for healthy Finnish adults. Values of less than 5.6 % ( < mean + 2 SD) were considered normal.
Three values of HbA were selected for this study: the first, the last and one during mid-pregnancy. Arithmetic differences between these three HbA 1 c values were calculated for each patient and used as the criterion for changes of glycaemic control during pregnancy. The first HbA 1 c assessment was carried out at a median of 7 weeks of gestation and in 93 % by the end of the 14th week. For the mid-pregnancy figure, the value obtained closest to 22 weeks was used (range 20±25 weeks). The last measurement during pregnancy occurred at a median of 2 weeks (range 0±4 weeks) before delivery.
Statistical methods. Of 683 pregnancies in women with Type I diabetes and 854 control women, the power of this study to detect a doubling of the frequency of pre-eclampsia (6 vs 3 %) was 81 % at a p-value of 0.05. Categorial variables were tested by Fisher's exact probability test or the chi-squared test with the Armitage test for trends in proportions. Continuous variables were compared by using Student's t test or the MannWhitney U test. Multiple logistic regression was used to assess the main effects of variables independently associated with the outcome. All tests were two-sided, and values of p less than 0.05 were considered statistically significant. Arcus Quickstat Biomedical software (Longman Software Publishing, Cambridge, UK) and NCSS 2000 (NCSS Inc., Cary, N. C., USA) were used for the calculations.
Results
Baseline characteristics. Compared with the control women, the women with diabetes were nulliparous and had essential hypertension more often. No statistically significant differences were observed in the ages of mothers, numbers of smokers and social class defined by the womens' educational level ( Table 1 ).
The women with diabetes had a significantly greater proportion of Caesarean sections and a shorter duration of gestation than the control subjects due to our practice of always doing elective Caesarean sections in White's class D and higher (Table 2) .
Glycaemic control. In women with diabetes, glycaemic control improved significantly during the first half of pregnancy: the mean HbA 1 c value dropped from 7.5 % (SD 1.4) in early pregnancy to 6.4 % (SD 1.0) in mid-pregnancy (p < 0.001). The mean HbA 1 c value at the end of pregnancy was 6.7 % (SD 1.1), which was significantly higher than at mid-pregnancy (p < 0.001).
Of the women with diabetes, 267 (39 %) had counselling before pregnancy; their mean HbA 1 c value up to 6 months before pregnancy was 7.5 % (SD 1.3).
Risk factors of pre-eclampsia. Pre-eclampsia developed in 12.8 % of the women with diabetes (excluding those with pre-pregnancy nephropathy) and in 2.7 % of the control women (OR 5.2; 95 % CI 3.3±8.4). A positive relation was observed between the HbA 1 c value in early pregnancy with the occurrence of pre-eclampsia. Advanced White's class also showed an association with an increased risk of preeclampsia (Table 3) .
We show the odds ratios for pre-eclampsia for the five variables that emerged as significant independent predictors in the logistic regression analysis done on the diabetic women (Table 4) . Each 1 % increment in the initial HbA 1 c value (e. g. from 7.0 to 8.0 %) increased the risk of pre-eclampsia 1.6-fold. Improvement of glycaemic control reduced the risk 0.6-fold for each 1 % decrement of HbA 1 c achieved until mid-pregnancy. The change of HbA 1 c value from mid-pregnancy until the end of pregnancy did not significantly alter the risk of pre-eclampsia (OR 0.8; 95 % CI 0.6±1.1 for each 1 % change).
The mothers' age, educational level, essential hypertension, twin pregnancy, BMI, pre-pregnancy insulin dose, insulin dose increment during pregnancy, smoking, or participation in pre-pregnancy planning did not show any pronounced association (p > 0.1) with pre-eclampsia.
Among the 267 diabetic women who had undergone pre-pregnancy planning, their pre-pregnancy HbA 1 c value showed an association with the occurrence of pre-eclampsia in their subsequent pregnancy (OR 1.4, 95 % CI 1.1±1.9 for each 1 % increment).
Subgroup with a low risk of pre-eclampsia. Among the 683 women with Type I diabetes there were 138 (20 %) who were parous, had no nephropathy or ret- Patients with pre-pregnancy nephropathy (White's class F). Of the 67 patients with pre-pregnancy nephropathy, 38 (57 %) were considered as having pre-eclampsia or PIH on the basis of the blood pressure criteria.
Proteinuria without increased blood pressure. There were 53 women with diabetes (7.8 %) and 23 control subjects (2.7 %) (p < 0.001) who developed proteinuria by the end of pregnancy but did not meet our blood pressure criteria. Some of these patients, however, probably had ªpre-eclampsiaº with minimal or no increase in blood pressure. The remainder showed only pregnancy-induced proteinuria, which is known to occur occasionally in normal healthy subjects [13, 14] . It was not possible to separate these two groups from one another due to the wellknown limitations in any definition of pre-eclampsia [15±18]. 
Discussion
Women with non-proteinuric Type I diabetes showed a five-fold risk of pre-eclampsia compared with the general obstetric cohort. This conforms with the results of previous studies in that there is a substantial increase of pre-eclampsia among women with Type I diabetes [6, 11] . Our results also confirm that diabetic nephropathy before pregnancy considerably accentuates this risk [4] . Assessment of microalbuminuria (although not carried out in our study) might be a useful indicator of increased risk of pre-eclampsia before and during pregnancy [4] . The incidence of pre-eclampsia among women with diabetes has been reported to be 10 to 25 % depending on material and definitions [2, 7, 11, 12] and is in accordance with our rate (12.8 %) . Of the several possibilities to define high blood pressure, we chose to use diastolic pressure and took into account the increment from baseline and the final level during late pregnancy. Using the blood pressure level alone would have resulted in the inclusion of many women with chronic hypertension of 90 mmHg or more with minimal or no increase during pregnancy [16] . On the other hand, an increase of 15 mmHg alone in normotensive women has no effect on pregnancy outcome in most cases [19] . Because every definition of hypertension and pre-eclampsia is defective in some way [17, 18] , compromises were also unavoidable in our study.
In addition to the overwhelming effects of nephropathy, the effects of nulliparity, retinopathy, duration of diabetes and glycaemic control emerged as statistically significant independent risk factors for pre-eclampsia. The mothers' age, educational level, essential hypertension and participation in pre-pregnancy planning did not show such an association.
In a recent Swedish report the mean HbA 1 c value in early pregnancy was higher among those diabetic women who developed pre-eclampsia than in those who did not [11] . Another study conducted in the United States suggested an increased risk of pre-eclampsia associated with HbA 1 c values higher than 8 % [9, 10] . Our results support these findings, showing that the relation between the early-pregnancy HbA 1 c value and the rate of pre-eclampsia is virtually linear. Each 1 % increment from the initial HbA 1 c value corresponded to a 1.6-fold increase in the risk of pre-eclampsia.
It has been suggested that reduction of a high HbA 1 c value during pregnancy below a cut-off point of 8 % reduces the risk of pre-eclampsia [9] but more detailed information on this relation is not available. Our results suggest that, after adjusting for the initial HbA 1 c value and other statistically significant confounding factors, each 1 % decrement in HbA 1 c achieved by mid-pregnancy reduces the risk of preeclampsia by a factor of 0.6. A change of HbA 1 c value during the latter half of pregnancy did not statistically significantly influence the risk of pre-eclampsia.
Pre-pregnancy counselling of women with Type I diabetes is recommended for many reasons, of which the risk of fetal malformations due to hyperglycaemia is perhaps the most important. The association between high HbA 1 c values and an increased risk of pre-eclampsia that we observed further stresses the need for appropriate counselling of young diabetic women before pregnancy.
Our results show the heterogeneity of women with Type I diabetes with regard to their risk of pre-eclampsia. For example, a parous woman without nephropathy or retinopathy, with diabetes for less than 15 years showed a risk of pre-eclampsia similar to that in women from the greater Helsinki area in general. This implies that obstetric follow-up of women with diabetes can be adjusted to each woman to a certain degree and not all of them need to be subjected to very intensive and expensive follow-up visits. There are many other factors, such as macrosomia [20] that must be taken into account when tailoring obstetric care for each of the mothers.
The risk of PIH among women with diabetes without nephropathy was twice that among control subjects. Unlike pre-eclampsia, the occurrence of PIH did not show an association with retinopathy or with the duration of diabetes. Neither was it associated with glycaemic control, which was also noted in the recent Swedish study [11] . This implies that pre-eclampsia and PIH in women with diabetes might be largely separate entities and the difference between these two disorders should probably be recognised in research as well as in clinical practice.
We conclude that poor glycaemic control in early pregnancy and failure to improve it during the first half of pregnancy are statistically significant risk factors for pre-eclampsia in women with Type I diabetes.
